Nisa Investment Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,674
| Closed | -$64.3K | – | 2884 |
|
|
2023
Q2 | $64.3K | Buy |
1,674
+730
| +77% | +$28K | ﹤0.01% | 1660 |
|
|
2023
Q1 | $22K | Hold |
944
| – | – | ﹤0.01% | 1988 |
|
|
2022
Q4 | $25K | Hold |
944
| – | – | ﹤0.01% | 2002 |
|
|
2022
Q3 | $20K | Buy |
944
+42
| +5% | +$890 | ﹤0.01% | 2061 |
|
|
2022
Q2 | $16K | Buy |
902
+570
| +172% | +$10.1K | ﹤0.01% | 2105 |
|
|
2022
Q1 | $5K | Sell |
332
-140
| -30% | -$2.11K | ﹤0.01% | 2318 |
|
|
2021
Q4 | $6K | Hold |
472
| – | – | ﹤0.01% | 2087 |
|
|
2021
Q3 | $6 | Hold |
472
| – | – | ﹤0.01% | 2250 |
|
|
2021
Q2 | $7 | Hold |
472
| – | – | ﹤0.01% | 2265 |
|
|
2021
Q1 | $7 | Hold |
472
| – | – | ﹤0.01% | 2244 |
|
|
2020
Q4 | $7K | Buy |
472
+200
| +74% | +$2.97K | ﹤0.01% | 2256 |
|
|
2020
Q3 | $3K | Hold |
272
| – | – | ﹤0.01% | 2229 |
|
|
2020
Q2 | $3K | Hold |
272
| – | – | ﹤0.01% | 2043 |
|
|
2020
Q1 | $4K | Buy |
+272
| New | +$4K | ﹤0.01% | 1987 |
|
|
2019
Q3 | – | Sell |
-300
| Closed | -$2K | – | 2060 |
|
|
2019
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 1989 |
|
|
2019
Q1 | $6K | Hold |
300
| – | – | ﹤0.01% | 1887 |
|
|
2018
Q4 | $4K | Buy |
300
+196
| +188% | +$2.61K | ﹤0.01% | 1859 |
|
|
2018
Q3 | $4K | Sell |
104
-40
| -28% | -$1.54K | ﹤0.01% | 1910 |
|
|
2018
Q2 | $5K | Hold |
144
| – | – | ﹤0.01% | 1838 |
|
|
2018
Q1 | $7K | Sell |
144
-4,740
| -97% | -$230K | ﹤0.01% | 1749 |
|
|
2017
Q4 | $183K | Buy |
4,884
+4,680
| +2,294% | +$175K | ﹤0.01% | 1288 |
|
|
2017
Q3 | $11K | Hold |
204
| – | – | ﹤0.01% | 1732 |
|
|
2017
Q2 | $12K | Buy |
204
+140
| +219% | +$8.24K | ﹤0.01% | 1671 |
|
|
2017
Q1 | $3K | Sell |
64
-56
| -47% | -$2.63K | ﹤0.01% | 1841 |
|
|
2016
Q4 | $7K | Sell |
120
-320
| -73% | -$18.7K | ﹤0.01% | 1837 |
|
|
2016
Q3 | $27K | Hold |
440
| – | – | ﹤0.01% | 1550 |
|
|
2016
Q2 | $25K | Buy |
+440
| New | +$25K | ﹤0.01% | 1544 |
|